Chitosan and chitosan nanoparticles as adjuvant in local Rift Valley Fever inactivated vaccine-Reference-Cited by-同舟云学术

Chitosan and chitosan nanoparticles as adjuvant in local Rift Valley Fever inactivated vaccine

Published:2020-02-04 Issue:3 Volume:10 Page:
ISSN:2190-572X
Container-title:3 Biotech
language:en
Short-container-title:3 Biotech

Author:

El-Sissi Ashgan F.,Mohamed Farida H.,Danial Nadia M.,Gaballah Ali Q.,Ali Korany A.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Agricultural and Biological Sciences (miscellaneous),Environmental Science (miscellaneous),Biotechnology

Link

http://link.springer.com/content/pdf/10.1007/s13205-020-2076-y.pdf

Reference45 articles.

1. AL-Nemrawi N, AL-Sharif SM, Daver RH (2018) Preparation of chitosan-TPP nanoparticles: the influence of chitosan properties and formulation variables. Int J Appl Pharm 10(5):60–65

2. Averhoff F, Mahoney F, Coleman P, Schatz G, Hurwitz E (1998) Immunogenicity of hepatitis B vaccines: implications for persons at occupational risk of hepatitis B virus. Am J Prev Med 15:1–8

3. Carroll EC, Jin L, Mori A, Muñoz-Wol N, Oleszycka E, Moran HBT, Mansouri S, Entee P, Lambe E, Agger EM, Andersen P, Cunningham C, Hertzog P, Fitzgerald KA, Bowie G, Lavelle EC (2016) The vaccine adjuvant chitosan promotes cellular immunity via DNA sensor cGAS-STING-dependent induction of type I interferons. Immunity 44(3):597–608

4. Coetzer JA (1982) The pathology of Rift Valley fever. II. Lesions occurring in field cases in adult cattle, calves and aborted foetuses. J Vet Res 49:11–17

5. Confavreux C, Suissa A, Saddier P, Bourdes V, Vukusic S (2001) Vaccinations and the risk of relapse of multiple sclerosis. Vaccines in multiple sclerosis group. N Engl J Med 344:319–326

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applications of Chitosan in Prevention and Treatment Strategies of Infectious Diseases;Pharmaceutics;2024-09-13

2. Biodegradable nanoplatforms for antigen delivery: part I – state of the art review of polymeric nanoparticles for cancer immunotherapy;Expert Opinion on Drug Delivery;2024-09-08

3. Co‐delivery of oncolytic virus and chemotherapeutic modality: Vincristine against prostate cancer treatment: A potent viro‐chemotherapeutic approach;Journal of Medical Virology;2024-07

4. Green Synthesized Chitosan Nanoparticles for Controlling Multidrug-Resistant mecA- and blaZ-Positive Staphylococcus aureus and aadA1-Positive Escherichia coli;International Journal of Molecular Sciences;2024-04-26

5. Exploring modified chitosan-based gene delivery technologies for therapeutic advancements;International Journal of Biological Macromolecules;2024-03